SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genzyme Tissue Repair - GZTR
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BWAC who wrote (188)6/17/1999 5:46:00 PM
From: KLH  Read Replies (1) of 405
 
The July/August issue of Men's Health magazine,
Carticle is covered on page 58 and 59, as the
answer in treating damaged knee cartilage. Too
bad the author didn't mention GZTR as the company
behind Carticle. Instead, they give a closing
paragraph to Advanced Tissue Sciences that is in
pre clinical FDA trials to grow "universal donor"
cartilage and its advantages over Carticle.


Karl
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News